WW International, Inc.'s SEC filings document the regulatory record for Weight Watchers' subscription-based weight-management and clinical businesses. Recent Forms 8-K furnish quarterly results, shareholder letters, Regulation FD disclosures about term-loan prepayment actions, and material governance events involving directors, board committees and interim executive officers.
The company's proxy materials cover annual-meeting voting matters, director elections, board independence, committee service and non-employee director compensation. Its filings also identify WW common stock, no par value, registered on the Nasdaq Stock Market and provide formal disclosure of capital-structure, compensation and corporate-governance matters.
WW International reported a challenging first quarter of 2026 as it continues operating post‑bankruptcy. Revenue was $168.3 million, down from $186.6 million a year earlier, with subscription revenue of $167.4 million. Higher marketing and overhead costs drove an operating loss of $30.4 million and a net loss of $52.0 million, or $5.20 per share.
Cash and cash equivalents were $120.9 million, but operations used $33.5 million of cash in the quarter. WW carries a $465.0 million New Term Loan Facility maturing in 2030 at an effective interest rate of about 10.5%, with a current portion of $26.8 million due. Goodwill totaled $200.0 million and the company flagged its Behavioral reporting unit and its $320.0 million trade name as at risk of future impairment, although no charges were recorded this quarter. WW also completed most actions under its 2025 restructuring plan and incurred additional restructuring charges while transitioning leadership after the CEO’s March 2026 resignation.
WW International reported first quarter 2026 results with revenue of $168.3 million and a net loss of $52.0 million. Subscription revenue was $167.4 million, including $128.5 million from Behavioral offerings and $38.8 million from faster‑growing Clinical offerings, where Clinical subscription revenue rose 31.8% year‑over‑year.
Total end‑of‑period subscribers were 2.659 million, with 2.463 million Behavioral and 197 thousand Clinical subscribers, as mix shifts toward higher‑value tiers lifted ARPU to $20.59, up 13% year‑over‑year. Adjusted EBITDA was a loss of $1.8 million, as marketing spending was front‑loaded to promote Med+ and GLP‑1 offerings, while Adjusted Gross Margin remained high at 73.6%.
The company ended the quarter with $120.9 million of cash and cash equivalents and long‑term debt of $438.6 million. It plans in Q2 to use $37 million of cash to retire $42 million of term‑loan principal, which is expected to cut annualized interest expense by approximately $4 million. Management reaffirmed full‑year 2026 guidance for revenue of $620–$635 million and Adjusted EBITDA of $105–$115 million, and continues to expect cash generation over the remaining quarters of 2026.
WW International is asking shareholders to vote at a virtual 2026 annual meeting on June 12, 2026. Proposals include electing six directors, ratifying PricewaterhouseCoopers as auditor for 2026, and approving executive pay in an advisory vote.
The proxy explains that the company emerged from Chapter 11 on June 24, 2025, cancelling prior equity and issuing 91% of new common stock to holders of Allowed First Lien Claims. It also outlines governance structures, committee independence, and 2025 compensation, including $12,681,801 for former CEO Tara Comonte.
WW INTERNATIONAL, INC. filed an amended Form 3 for Chief Operations Officer Jonathan Volkmann to correct his reported holdings of common stock. The amendment shows he directly owns 1,696 shares of Common Stock and clarifies that 1,144 shares had been omitted from the original Form 3; all other information remains unchanged.
WW International director Heather Thiltgen filed an initial ownership report with the SEC. This Form 3 filing identifies her as a director of WW International, Inc. and serves as her baseline disclosure of beneficial ownership in the company. The filing does not list any specific transactions.
WW International plans to use up to $40 million of cash to prepay and reduce the principal on its outstanding term loan, lowering its debt balance. This action is described as part of broader efforts to strengthen liquidity and deleverage the balance sheet.
The company also reaffirmed its first quarter 2026 end-of-period subscriber estimates and full-year 2026 financial guidance previously issued on March 16, 2026. Based on that guidance, management expects to generate cash over the rest of the year after heavier first-quarter marketing spending.
WW International, Inc. appointed Heather Thiltgen to its Board of Directors, effective April 20, 2026, increasing the Board size to six members. She will serve until the Company’s 2026 annual meeting of shareholders and is expected to stand for election at that meeting.
The Board determined that Ms. Thiltgen is an independent director under Nasdaq rules and also named her to the Compensation and Benefits Committee. She will receive an annual cash retainer of $90,000 plus $12,500 for committee service, prorated for fiscal 2026, and may receive restricted stock units with a target value of $135,000 following shareholder election.
Cotter Debra reported acquisition or exercise transactions in this Form 4 filing.
WW International, Inc. Chief Legal Officer and Secretary Debra Cotter received equity awards in the form of derivatives tied to common stock. She was granted 2,666 Restricted Stock Units and 1,200 Performance Stock Units, each representing a contingent right to receive one share of common stock.
The awards were granted on April 15, 2026 and will vest in three equal installments on January 1, 2027, January 1, 2028 and January 1, 2029. The Performance Stock Units also require continued employment through January 1, 2029 and satisfaction of stock price performance conditions measured using volume weighted average closing prices over specified 20‑day periods.
WW International executive Debra Cotter reported her initial ownership on Form 3. She directly holds 1,109 shares of common stock and restricted stock units representing 6,666 underlying common shares. These RSU awards, granted on December 18, 2025, vest one-third on each of January 1, 2027, 2028 and 2029 and expire on January 1, 2029.